VEGF receptor signaling and endothelial function
- PMID: 11795595
- DOI: 10.1080/15216540252774784
VEGF receptor signaling and endothelial function
Abstract
Angiogenesis, the formation of new blood vessels from preexisting ones, is a central process during normal development and during pathological repair. Vascular endothelial growth factor-A (VEGF-A) can stimulate both physiological and pathological angiogensis. VEGF-A is a ligand for the two receptor tyrosine kinases VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1). Most biological functions of VEGF-A are mediated via VEGFR-2, whereas the role of VEGFR-1 is largely unknown. Activation of mitogen-activated kinase, stress-activated kinase, protein kinase C, and the Akt pathway are implicated in VEGF-A-dependent endothelial function, including cell survival, proliferation, generation of nitric oxide, and the induction of angiogenesis. Induction of metalloproteinases, activation of focal adhesion kinase and of PI3-kinase are implicated in VEGF-A-induced endothelial cell migration. The important role of nitric oxide as a mediator of endothelial function in vivo links the receptor signaling network to other biological effects.
Similar articles
-
VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.Exp Cell Res. 2001 Feb 1;263(1):173-82. doi: 10.1006/excr.2000.5102. Exp Cell Res. 2001. PMID: 11161716
-
Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.Cancer Res. 2001 Oct 1;61(19):7002-8. Cancer Res. 2001. PMID: 11585724
-
Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system.Cancer Res. 1997 Sep 1;57(17):3852-9. Cancer Res. 1997. PMID: 9288799
-
Lymphatic versus blood vascular endothelial growth factors and receptors in humans.Microsc Res Tech. 2001 Oct 15;55(2):108-21. doi: 10.1002/jemt.1162. Microsc Res Tech. 2001. PMID: 11596156 Review.
-
Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family.Cardiovasc Res. 2001 Feb 16;49(3):568-81. doi: 10.1016/s0008-6363(00)00268-6. Cardiovasc Res. 2001. PMID: 11166270 Review.
Cited by
-
Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta.Biomolecules. 2020 Jun 24;10(6):953. doi: 10.3390/biom10060953. Biomolecules. 2020. PMID: 32599856 Free PMC article. Review.
-
Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage.Biomol Ther (Seoul). 2019 Sep 1;27(5):423-434. doi: 10.4062/biomolther.2019.051. Biomol Ther (Seoul). 2019. PMID: 31113013 Free PMC article.
-
Association of genetic polymorphisms in vascular endothelial growth factor with susceptibility to coronary artery disease: a meta-analysis.BMC Med Genet. 2018 Jul 4;19(1):108. doi: 10.1186/s12881-018-0628-3. BMC Med Genet. 2018. PMID: 29973139 Free PMC article.
-
Indispensable Role of HIF-1α Signaling in Post-implantation Survival and Angio-/Vasculogenic Properties of SHED.Front Cell Dev Biol. 2021 Jul 23;9:655073. doi: 10.3389/fcell.2021.655073. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34368116 Free PMC article.
-
A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy.Int J Mol Sci. 2017 Aug 17;18(8):1786. doi: 10.3390/ijms18081786. Int J Mol Sci. 2017. PMID: 28817103 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources